Letter: Double-Dose Intensification - A Quick Way to Reverse Antibody Formation and Loss of Response in Patients Treated With Adalimumab

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.15124
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Letter: Double-Dose Intensification-A Quick Way to Reverse Antibody Formation and Loss of Response in Patients Treated With Adalimumab. Authors Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Letter: Can Addition of an Immunomodulator Really Reverse Antibody Formation and Loss of Response in Patients Treated With Adalimumab?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Letter: Can Addition of an Immunomodulator Really Reverse Antibody Formation and Loss of Response in Patients Treated With Adalimumab? Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Dose Escalation Among Ulcerative Colitis Patients Treated With Adalimumab in Sweden

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Antibody Response to a Standard Dose of Hepatitis B Vaccine in HIV-Infected Patients

Klimik Dergisi
Infectious DiseasesMicrobiology
2015English

Erratum To: Practical Application of Acid Dissociation in Monitoring Patients Treated With Adalimumab

Rheumatology International
RheumatologyAllergyImmunology
2014English

Response to Letter Regarding Article, "Proportion of Patients Treated With Thrombolysis in a Centralized Versus a Decentralized Acute Stroke Care Setting"

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2012English

Letter: Is There a Role for Infliximab Biosimilar in Patients With Inflammatory Bowel Disease With Secondary Loss of Response to Infliximab Innovator?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Dose Sparing and the Lack of a Dose-Response Relationship With an Influenza Vaccine in Adult and Elderly Patients - A Randomized, Double-Blind Clinical Trial

British Journal of Clinical Pharmacology
Pharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy